Matthew J. Abrams

Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

Matthew J. Abrams, Malik E. Juweid, C I tenKate et al. · PubMed · 1990 · 361 citations

Technetium-99m-human Polyclonal Igg, Immunocytochemical Technique, Engineering +28

A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.

B. Leonard Holman, Alun G. Jones, John Lister‐James et al. · PubMed · 1984 · 176 citations

Heart Failure, Imaging Agent, Biomedical Engineering +20

Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis

Matthew J. Abrams, P.P. Koffer, David E. Wazer et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 42 citations

Surgical Oncology, Breast Oncology, Improved Survival +8

Emerging strategies to promote improved functional outcome after peripheral nerve injury

Matthew J. Abrams, Johan Widenfalk · Restorative Neurology and Neuroscience · 2005 · 40 citations

Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study.

Matthew J. Abrams, Kathryn E. Huber, Jonathan Knisely et al. · PubMed · 2015 · 37 citations